Left ventricular wall myocardium structural and functional indices change in patients with arterial hypertension and subclinical hypothyroidism treated with hypotensives

Abstract

Aim. To assess the left ventricular wall myocardium structural and functional indices change over time in patients receiving hypotensive treatment for arterial hypertension associated with subclinical hypothyroidism. Methods. Sixty eight patients with arterial hypertension and subclinical hyperthyroidism were distributed to two groups. Patients of the group 1 (37 patients) received amlodipine (5-10 mg/day) and indapamide (1.5 mg/day), patients of the group 2 (31 patients) received lisinopril (5-10 mg/day) and indapamide (1.5 mg/day). Carotid artery ultrasonography and echocardiography were performed using «Philips» HD-11 XE (USA) scanner on the baseline and after 18 months of treatment. Results. Initial parameters of the left ventricular wall myocardium in all patients were comparable. Significant increase in early diastolic left ventricular filling velocity by 5.2%, decrease of late diastolic filling velocity by 11.4%, increase of peak velocities ratio on the mitral valve by 19.7% were revealed in patients of group 1 after 18 months of treatment compared to baseline. Increase in early diastolic left ventricular filling velocity by 7.0%, increase of peak velocities ratio on the mitral valve by 13.9% were registered in patients of group 2. No signs of concentric left ventricle remodeling were revealed. The share of patients with eccentric hypertrophy was not altered (18.9 and 12.9%, respectively). Conclusion. Treatment with amlodipine + indapamine and lisinopril + indapamine during 18 months improves left ventricle diastolic function.

Keywords

arterial hypertension / subclinical hypothyroidism / hypotensive treatment / echocardiography / left ventricle remodeling

References

[1] Бланкова З.Н., Серединина Е.М., Агеев Ф.Т. Влияние терапии левотироксином на клинический, гемодинамический и нейрогуморальный статус больных сердечной недостаточностью в сочетании с субклиническим гипотиреозом // Серд. недост. - Т. 12, №1. - С. 18-22.

[2] Васюк Ю.А. Возможности и ограничения эхокардиографического исследования в оценке ремоделирования левого желудочка при ХСН // Серд. недост. - 2007. - Т. 4, №2. - С. 107-110.

[3] Диагностика и лечение артериальной гипертензии. Российское медицинское общество по артериальной гипертонии (РМОАГ), Всероссийское научное общество кардиологов (ВНОК). Российские рекомендации (четвёртый пересмотр) // Системн. гипертенз. - 2010. - №3. - С. 5-26.

[4] Подзолков А.В., Фадеев А.А. Гипотиреоз, субклинический гипотиреоз, высоконормальный уровень ТТГ // Клин. и эксперим. тиреоидол. - 2009. - Т. 5, №2. - С. 4-16.

[5] Трошина Е.А., Юкина М.Ю., Огнева Н.А., Мазурина Н.В. Нарушения функции щитовидной железы и сердечно-сосудистая система // Клин. и эксперим. тиреоидол. - 2010. - Т. 6, №1. - С. 12-19.

[6] Aghini Lombardi F., Di Bello V., Talini E. et al. Early textural and functional alterations of left ventricular myocardium in mild hypothyroidism // Eur. J. Endocrinol. - 2006. - Vol. 155. - P. 3-9.

[7] Brilla C.G. Regression of myocardial fibrosis in hypertensive heart disease: diverse effects of various antihypertensive drugs // Cardiovasc. Res. - 2000. - Vol. 46, N 2. - P. 324-331.

[8] Hak A.E., Pols H.A.P., Visser T.J. et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study // Ann. Intern. Med. - 2000. - Vol. 132. - P. 270-278.

[9] Hamilton O.A., Davis S., Onstad L. et al. Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism // J. Clin. Endocrinol. Metab. - 2008. - Vol. 93, N 4. - P. 1224-1230.

[10] Helfand M. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force // Ann. Intern. Med. - 2004. - Vol. 140. - P. 128-141.

[11] Igbal A., Figenschau Y., Jorde R. Blood pressure in relation to serum thyrotropin: the Tromso study // J. Hum. Hypertens. - 2006. - Vol. 20. - P. 932-936.

[12] Igbal A., Schirmer H., Lunde P. et al. Thyroid stimulating hormone and left ventricular function // J. Clin. Endocrinol. Met. - 2007. - Vol. 92. - P. 3504-3510.

[13] Kahaly G.J. Cardiovascular and atherogenic aspects of subclinical hypothyroidism // Thyroid. - 2000. - Vol. 10, N 8. - P. 665-679.

[14] Luboshitzky R., Aviv A., Herer P., Lavie L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism // Thyroid. - 2002. - Vol. 12, N 5. - P. 421-425.

[15] Okada M., Kosaka N., Hoshino U. et al. Effects of captopril and telmisartan on matrix metalloproteinase-2 and -9 expressions and development of left ventricular fibrosis induced by isoprenaline in rats // Biol. Pharm. Bull. - 2010. - Vol. 33, N 9. - P. 1517-1521.

RIGHTS & PERMISSIONS

Soldatenko N.V., Yeliseyeva L.N., Zhdamarova O.I.